Compounds > peptide elongation factor 2
Page last updated: 2024-08-26

peptide elongation factor 2 and Lung Neoplasms

peptide elongation factor 2 has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, HW; Chen, CY; Chiang, IP; Chiang, SF; Chiou, SH; Chow, KC; Fang, HY; Huang, CY; Lin, TY; Yi, SE1

Other Studies

1 other study(ies) available for peptide elongation factor 2 and Lung Neoplasms

ArticleYear
Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells.
    Cancer science, 2011, Volume: 102, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Female; Humans; Lung Neoplasms; Male; Mitochondria; Peptide Elongation Factor 2; Prognosis; Protein Stability; Sumoylation

2011